Dongliang Xu

6PUBLICATIONS
7CO-AUTHORS
Molecular targetsPredictive and prognostic markersNeurology and neuromuscular diseasesToxicology (incl. clinical toxicology)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 05, 2026
Mepce Restrains Ferroptosis in Prostate Cancer Through 7SK-P-TEFb Pause Control.

|Jul 06, 2026
Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non-Invasive Diagnosis of Bladder Cancer.

|Feb 09, 2026
Wnt11 mediates fibroblast-smooth muscle cell interaction to promote neurogenic bladder fibrosis in rats.

Qingyu Ge, Junjie Zhang, Zongyao Fan

|Oct 06, 2025
Saikosaponin‑D triggers cancer cell death by targeting the PIM1/c-Myc axis to reprogram oncogenic alternative splicing.

Xin Zhang, Xuehui Li, Feng Zhang

|Jan 03, 2024
PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking.

Mingyue Tan, Qi Pan, Chao Yu

|Feb 06, 2023
Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy.

Xinglin Chen, Tongtong Zhang, Xiangyang Zhan

Pageof 1

Frequent Collaborators

2 joint publications

Jianyi Gu

2 joint publications

Mingyue Tan

1 joint publications

Mingyue Tan

1 joint publications

Fuwen Yuan